Locations
United States · New York County, NY, USA · New York, USA · New York, NY, USA · Manhattan, New York, NY, USA · Soho, New York, NY, USA · Soho, New York, NY, USA
industry
Biotechnology · DeepTech · Health
Size
11-50 employees
Stage
Other
founded in
2017
Embleema is a pioneering data and bioinformatics platform that integrates molecular, clinical, and real-world data to enhance personalized medicine. Their unique end-to-end data platform supports the entire clinical trial process, from patient recruitment to regulatory submission, utilizing blockchain technology to ensure data integrity and participant consent. With a focus on improving patient involvement and satisfaction, Embleema accelerates regulatory approvals and reduces costs for sponsors, positioning itself as a leader in the real-world evidence space. The platform's innovative approach and strong partnerships with organizations like the FDA and various biotech firms highlight its significant traction and market position.
Is this your company?
Something looks off?
